Lostrancos

Recent Articles

RELATED ARTICLES

  1. This biopharmaceutical company reported a surge in half-year revenues but logged a bigger net loss, as investors look ahead to the launch of its new weight-loss drug.
    Innovent Bio hopes for plus-sized profits from obesity drug
    1801.HK
  2. CSPC Pharma taps R&D superstar in quest for new breakout drugs
    1093.HK
  3. Ascentage Pharma soars on deal with cancer drug competitor
    6855.HK
  4. Test results for new cancer drug take Akeso investors on wild ride
    9926.HK
  5. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  6. Akeso marks profit milestone with swift rights issue
    9926.HK
  7. Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
    1672.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva